Cholesterol in Mitochondrial Diseases-Friend or Foe?

Area of Science:

• Cellular Biology
• Biochemistry
• Genetics

Background:

• Mitochondria are vital for cellular homeostasis and metabolism.
• Mitochondrial diseases stem from DNA mutations, causing multi-systemic and often fatal disorders.
• Heterogeneity in mitochondrial distribution and phenotype complicates disease understanding.

Purpose of the Study:

• To review evidence linking cholesterol dyshomeostasis to mitochondrial disease.
• To explore cholesterol's role as a potential unifying pathological hallmark.
• To discuss statin intolerance in the context of mitochondrial cholesterol metabolism.

Main Methods:

• Literature review of experimental studies.
• Analysis of cell, animal, and human data on cholesterol metabolism in mitochondrial disease.
• Synthesis of evidence regarding cholesterol biosynthesis, import, and ratios.

Main Results:

• Growing evidence suggests cholesterol dyshomeostasis is implicated in various mitochondrial diseases.
• Perturbations in cholesterol pathways are reported across different models and patient populations.
• Cholesterol imbalance may represent a common feature across diverse mitochondrial disorders.

Conclusions:

• Cholesterol dyshomeostasis is a potential unifying pathological hallmark of mitochondrial disease.
• Further integrated clinical and experimental studies are necessary.
• Understanding this link may improve clinical management and patient outcomes.